Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000930413-01-500008
Filing Date
2001-03-08
Accepted
2001-03-08 00:00:00
Documents
24
Period of Report
2001-04-26

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE NOTICE AND PROXY STATEMENT c19779-def14a.htm DEF 14A 547953
2 GRAPHIC brown.jpg GRAPHIC 10219
3 GRAPHIC burns.jpg GRAPHIC 9407
4 GRAPHIC burt.jpg GRAPHIC 9536
5 GRAPHIC cornwell.jpg GRAPHIC 10624
6 GRAPHIC cover.gif GRAPHIC 153593
7 GRAPHIC d19799_chart.gif GRAPHIC 7276
8 GRAPHIC gray.jpg GRAPHIC 10589
9 GRAPHIC horner.jpg GRAPHIC 10400
10 GRAPHIC howell.jpg GRAPHIC 10528
11 GRAPHIC ikenberry.jpg GRAPHIC 9923
12 GRAPHIC kamen.jpg GRAPHIC 10195
13 GRAPHIC lorch.jpg GRAPHIC 10601
14 GRAPHIC mandl.jpg GRAPHIC 12503
15 GRAPHIC map2.gif GRAPHIC 40314
16 GRAPHIC mckinnell.jpg GRAPHIC 10223
17 GRAPHIC mead.jpg GRAPHIC 9616
18 GRAPHIC niblack.jpg GRAPHIC 10161
19 GRAPHIC pfizerlogo.gif GRAPHIC 844
20 GRAPHIC raines.jpg GRAPHIC 11256
21 GRAPHIC simmons.jpg GRAPHIC 9949
22 GRAPHIC sovern.jpg GRAPHIC 10102
23 GRAPHIC steere.jpg GRAPHIC 10412
24 GRAPHIC valles.jpg GRAPHIC 11490
  Complete submission text file 0000930413-01-500008.txt   951706
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-03619 | Film No.: 1563691
SIC: 2834 Pharmaceutical Preparations